These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 27426130)
1. Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy. Zheng YC; Ma JL; Liu Y; Liu HM Curr Pharm Des; 2016; 22(39):5943-5947. PubMed ID: 27426130 [TBL] [Abstract][Full Text] [Related]
3. Functional coupling between writers, erasers and readers of histone and DNA methylation. Torres IO; Fujimori DG Curr Opin Struct Biol; 2015 Dec; 35():68-75. PubMed ID: 26496625 [TBL] [Abstract][Full Text] [Related]
4. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Bhat KP; Ümit Kaniskan H; Jin J; Gozani O Nat Rev Drug Discov; 2021 Apr; 20(4):265-286. PubMed ID: 33469207 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of histone lysine methylation: structures of methyl writers and erasers. Upadhyay AK; Cheng X Prog Drug Res; 2011; 67():107-24. PubMed ID: 21141727 [TBL] [Abstract][Full Text] [Related]
6. Writing, erasing and reading histone lysine methylations. Hyun K; Jeon J; Park K; Kim J Exp Mol Med; 2017 Apr; 49(4):e324. PubMed ID: 28450737 [TBL] [Abstract][Full Text] [Related]
7. Oncoepigenomics: making histone lysine methylation count. Decarlo D; Hadden MK Eur J Med Chem; 2012 Oct; 56():179-94. PubMed ID: 22975593 [TBL] [Abstract][Full Text] [Related]
8. Lysine methylation of transcription factors in cancer. Han D; Huang M; Wang T; Li Z; Chen Y; Liu C; Lei Z; Chu X Cell Death Dis; 2019 Mar; 10(4):290. PubMed ID: 30926778 [TBL] [Abstract][Full Text] [Related]
9. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis. Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752 [TBL] [Abstract][Full Text] [Related]
10. Mind the methyl: methyllysine binding proteins in epigenetic regulation. Wagner T; Robaa D; Sippl W; Jung M ChemMedChem; 2014 Mar; 9(3):466-83. PubMed ID: 24449612 [TBL] [Abstract][Full Text] [Related]
11. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases. Wang Z; Patel DJ Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894 [TBL] [Abstract][Full Text] [Related]
12. Tug of war: adding and removing histone lysine methylation in Arabidopsis. Xiao J; Lee US; Wagner D Curr Opin Plant Biol; 2016 Dec; 34():41-53. PubMed ID: 27614255 [TBL] [Abstract][Full Text] [Related]
13. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Black JC; Van Rechem C; Whetstine JR Mol Cell; 2012 Nov; 48(4):491-507. PubMed ID: 23200123 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy. Biswas S; Rao CM Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562 [TBL] [Abstract][Full Text] [Related]
15. Errors in erasure: links between histone lysine methylation removal and disease. Duncan EM; Allis CD Prog Drug Res; 2011; 67():69-90. PubMed ID: 21141725 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic small molecule modulators of histone and DNA methylation. Hauser AT; Robaa D; Jung M Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619 [TBL] [Abstract][Full Text] [Related]
18. LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells. Jin Y; Huo B; Fu X; Cheng Z; Zhu J; Zhang Y; Hao T; Hu X Biomed Pharmacother; 2017 Aug; 92():896-904. PubMed ID: 28601046 [TBL] [Abstract][Full Text] [Related]